Posts
-
Clinical Trials Evaluate New Treatment for Anal Cancer
The addition of the drug cetuximab to standard chemoradiation reduced the incidence of relapse for patients with anal cancer, but was associated with significant adverse effects, according to recent Northwestern Medicine clinical trials.
-
Scientists Identify Structural Changes in Herpesvirus Fusion
Northwestern and Stanford scientists have uncovered new details on the structure of herpesviruses that allow them to initiate a fusion event to infect host cells.
-
Celebrating a Half-Century of Leadership in Bone Biology
Former and current colleagues, students and friends gathered to celebrated the career of Paula Stern, PhD, an authority on bone and mineral health research, and a respected leader and educator.